Fundraising FoxPrimorigen
1 known investors
Find your way into Primorigen
Sign up to see every warm intro you have to Primorigen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Primorigen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
Investors · 1
Non-dilutive funding · 14 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| NASA | Phase I | 2018 | $124.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $179.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $455.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $399.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $224.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $210.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $344.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $328.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $343.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2010 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2010 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $184.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $362.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Primorigen do?
- Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
- Who are Primorigen's investors?
- Primorigen's investors include Louisiana Funds.